Work

Preliminary result of first-line orelabrutinib plus R-CHOP in CD5-positive diffuse large B-cell lymphoma (Rocket trial): A single-arm, phase II trial

Year: 2025

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2025-3690

Authors: Qingqing Cai, Yi Xia, Shenrui Bai, Tao Zhan, Qinghua Lan, Jianbo Liu, Zi-Jian Li, Qingfang Zeng, Runhui Zheng, Shuling Zhang, Qihua Zou, Bing BAI, Xiaojie Fang, Xiaoxiao Wang, Man Nie, Hang Yang

Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Guangzhou Medical University, First Hospital of Lanzhou University

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417017013

Cites:

Cited by:

Related to: